[[4-(1-甲基-1-苯基乙基)苯氧基]甲基]-环氧乙烷 | 61578-04-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: [[4-(1-甲基-1-苯基乙基)苯氧基]甲基]-环氧乙烷
• 中文别名: 对-异丙苯基苯基缩水甘油醚
• 英文名称: 1,2-Epoxy-3-<4-(1-methyl-1-phenyl-aethyl)-phenoxy>-propan
• 英文别名: {[4-(α,α-dimethylbenzyl)phenoxy]methyl}oxirane；glycidyl 4-cumylphenyl ether；4-(1-Methyl-1-phenylethyl)-phenyl glycidyl ether；2-(4-(1-methyl-1-phenyl-ethyl)-phenoxymethyl)-oxirane；p-Cumylphenyl glycidyl ether；2-[[4-(2-phenylpropan-2-yl)phenoxy]methyl]oxirane
• CAS: 61578-04-9
• 化学式: C₁₈H₂₀O₂
• mdl: MFCD06660497
• 分子量: 268.356
• InChiKey: MHTUIBIYJWEQKA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  21.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  [[4-(1-甲基-1-苯基乙基)苯氧基]甲基]-环氧乙烷 、 2,2,6,6-四甲基-4-哌啶基苯甲酸酯 以59.2%的产率得到4-benzoyloxy-2,2,6,6-tetramethyl-1-[2-hydroxy-3-(4-cumylphenoxy)propyl]piperidine
  参考文献：
  名称：

  Piperidine derivatives

  摘要：

  式(I)的化合物：其中：R代表H或单酰基或多酰基群；R¹代表H或羧酸酯基；R²代表烷基、烯基、炔基、芳基或芳基烷基，这些基团可选择性地被取代，或者R²代表羧酸酯基；n = 1 - 4；Y为O或S；及其酯，可用作聚合材料的热稳定剂和光稳定剂。

  公开号：

  EP0583971A1
• 作为产物：
  描述：

  4-肉桂苯酚 、 环氧氯丙烷 生成 [[4-(1-甲基-1-苯基乙基)苯氧基]甲基]-环氧乙烷
  参考文献：
  名称：

  SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF

  摘要：

  本发明涉及一系列取代二氢和四氢噁唑嘧啶酮，具体地，涉及一系列式(I)的2-取代-2,3-二氢噁唑并[3,2-a]嘧啶-7-酮和2-取代-2,3,5,6-四氢噁唑并[3,2-a]嘧啶-7-酮：其中p，n，X，Y，R1，R2，R3，R4，R5，R6，R7和R8如所定义。本发明还涉及制备这些化合物的方法，包括新型中间体。本发明的化合物是代谢型谷氨酸受体(mGluR)的调节剂，特别是mGluR2受体。因此，本发明的化合物在制药领域中有用，特别是在治疗和/或预防各种中枢神经系统疾病(CNS)，包括但不限于急性和慢性神经退行性疾病、精神病、惊厥、焦虑、抑郁、偏头痛、疼痛、睡眠障碍和呕吐等方面。

  公开号：

  US20100075994A1

文献信息

• ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND BETA-DIKETONE COMPOUND
  申请人：Yamada Takashi

  公开号：US20100129753A1

  公开（公告）日：2010-05-27

  An alkali developable photosensitive resin composition contains (J) a photopolymerizable unsaturated compound having a structure resulting from the addition reaction of (B) a compound having a β-diketone moiety or a compound having a β-ketoester group to the (meth)acryloyl group of (A) a compound having at least two (meth)acryloyl groups and a hydroxyl group and subsequent esterification of the hydroxyl group of the resulting addition product with (C) a polybasic acid anhydride. The compound having a β-diketone moiety is preferably a novel β-diketone compound represented by general formula (I): wherein R 1 is a C1-C20 alkyl group; R 2 represents R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 , or CN; R 11 , R 12 , and R 13 are each hydrogen, a C1-C20 alkyl group, etc.; a is 0 to 3; and b is 0 to 4.

  一种可由碱显影的光敏树脂组合物，含有（J）一种光聚合不饱和化合物，该化合物的结构是由（B）含β-二酮基团或含β-酮酯基团的化合物与（A）含至少两个(甲基)丙烯酰基团和一个羟基的化合物中的(甲基)丙烯酰基团发生加成反应，并随后将所得加成产物的羟基与（C）多元酸酐进行酯化反应得到的。含β-二酮基团的化合物最好是表示为通用公式（I）的一种新型β-二酮化合物：其中R1是C1-C20烷基团；R2代表R11、OR11、COR11、SR11、CONR12R13或CN；R11、R12和R13分别是氢、C1-C20烷基团等；a是0到3；b是0到4。
• SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
  申请人：CAO Bin

  公开号：US20100075994A1

  公开（公告）日：2010-03-25

  The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.

  本发明涉及一系列取代二氢和四氢噁唑嘧啶酮，具体地说，涉及一系列式(I)的2-取代-2,3-二氢-噁唑并[3,2-a]嘧啶-7-酮和2-取代-2,3,5,6-四氢-噁唑并[3,2-a]嘧啶-7-酮： 其中p、n、X、Y、R1、R2、R3、R4、R5、R6、R7和R8如本文所定义。本发明还涉及制备这些化合物的方法，包括新颖的中间体。本发明的化合物是代谢型谷氨酸受体（mGluR）的调节剂，特别是mGluR2受体。因此，本发明的化合物在药物制剂中具有用途，特别是在治疗和/或预防各种中枢神经系统疾病（CNS）方面，包括但不限于急性和慢性神经退行性疾病、精神病、癫痫、焦虑、抑郁、偏头痛、疼痛、睡眠障碍和呕吐。
• NOVEL COMPOUND, DYE AND COLORED PHOTOSENSITIVE COMPOSITION
  申请人：Maeda Yosuke

  公开号：US20130296455A1

  公开（公告）日：2013-11-07

  Disclosed are a dye that is excellent in solubility and heat-resistance, and a novel compound that is suitable for the dye, and specifically provides a yellow dye having a maximum absorption wavelength in the region of 420 to 470 nm. Also disclosed are a colored (alkali-developable) photosensitive composition and an optical filter using the dye, and specifically provides a color filter that does not decrease luminance and thus is preferable for an image display device such as a liquid crystal display panel. Specifically, disclosed are a novel compound represented by the following general formula (1), a dye using the compound, and a colored (alkali-developable) photosensitive composition and a color filter. The content of the above-mentioned general formula (1) is as described in the description.

  揭示了一种在溶解性和耐热性方面表现优异的染料，以及一种适用于该染料的新化合物，具体提供了在420至470纳米波长区域具有最大吸收波长的黄色染料。还公开了一种着色（碱可显影）光敏组合物和使用该染料的光学滤光片，具体提供了一种不降低亮度且适用于像液晶显示面板等图像显示设备的彩色滤光片。具体地，公开了以下通用公式（1）表示的新化合物，使用该化合物的染料，以及着色（碱可显影）光敏组合物和彩色滤光片。上述通用公式（1）的内容如描述中所述。
• OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND
  申请人：ADEKA CORPORATION

  公开号：US20170166575A1

  公开（公告）日：2017-06-15

  The present invention provides oxime ester compounds represented by general formula (I), a photopolymerization initiator using said compound, and a photosensitive composition, alkali-developable photosensitive resin composition, and colored alkali-developable photosensitive resin composition containing same, and cured products thereof. The compounds of the present invention have excellent stability and low sublimability, and are useful as highly sensitive photopolymerization initiators that are activated by efficiently absorbing near ultraviolet light of 365 nm, etc. (I) (See the Specification for the definitions of R 1 -R 8 in the formula. n represents 0 or 1.)

  本发明提供了一种由通用式（I）表示的肟酯化合物，使用该化合物的光聚合引发剂，以及包含相同化合物的光敏组合物、可碱开发的光敏树脂组合物和着色的可碱开发的光敏树脂组合物及其固化产品。本发明的化合物具有优异的稳定性和低升华性，并且可作为高灵敏度的光聚合引发剂，通过高效吸收365纳米等近紫外光激活。（I）（有关R1-R8在式中的定义，请参见说明书。n代表0或1。）
• NOVEL COMPOUND HAVING alpha-CYANOACRYLATE STRUCTURE, DYE, AND COLORED PHOTOSENSITIVE COMPOSITION
  申请人：Maeda Yosuke

  公开号：US20140005292A1

  公开（公告）日：2014-01-02

  A compound represented by the following general formula (1). In the formula, A represents a benzene ring, a naphthalene ring and the like, wherein these rings may be substituted with a halogen atom and the like, R 1 represents a hydrogen atom and the like, R 2 represents a C 1-35 hydrocarbon group having or not having at least one group selected from an epoxy group, 4-vinylphenyl group and a (meth)acryloyloxy group, or a hydrogen atom, wherein at least one of R 2 with n occurrences is a C 3-35 hydrocarbon group having at least one group selected from an epoxy group, a 4-vinylphenyl group and a (meth)acryloyloxy group, n represents an integer of 1 to 6, and X represents a nitrogen atom, an oxygen atom, a sulfur atom, a phosphorus atom, or an n-valent organic group having 35 or less carbon atoms.

  以下为通式（1）所代表的化合物。其中，A代表苯环、萘环等，这些环可能被卤素等取代，R1代表氢原子等，R2代表具有或不具有环氧基团、4-乙烯基苯基团和（甲基）丙烯酰氧基团中至少一种基团的C1-35碳氢基团或氢原子，其中R2中至少有一个出现n次的基团是具有至少一种环氧基团、4-乙烯基苯基团和（甲基）丙烯酰氧基团中的一种的C3-35碳氢基团，n表示1到6的整数，X表示氮原子、氧原子、硫原子、磷原子或具有35个或更少碳原子的n价有机基团。